EIKN
Eikon Therapeutics, Inc.
$9.43-0.17 (-1.77%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖AI Insight
Latest Insider Transactions
Showing 10 of 40 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | Klobuchar Michael A | COO | Award | 87,157 | $14.88 | $1,296,896 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Huffines Robert Luther | Director | Award | 25,873 | $14.88 | $384,990 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Frazier Kenneth C | Director | Award | 25,873 | $14.88 | $384,990 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Perlmutter Roger M | See Remarks | Award | 268,176 | $14.88 | $3,990,459 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Thorner Benjamin Bruno | See Remarks | Award | 67,044 | $14.88 | $997,615 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Baynes Roy D. | CMO | Award | 134,088 | $14.88 | $1,995,229 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Bowie Alfred Lloyd Jr. | CFO | Award | 67,044 | $14.88 | $997,615 | N/A | N/A |
| 2026-02-09 | 2026-02-06 | Column Group Iv Gp, Lp | 10% Owner | Conversion | 3,785 | $0.00 | $0 | N/A | N/A |
| 2026-02-09 | 2026-02-06 | Column Group Iv Gp, Lp | 10% Owner | Conversion | 44,249 | $0.00 | $0 | N/A | N/A |
| 2026-02-09 | 2026-02-06 | Column Group Iv Gp, Lp | 10% Owner | Conversion | 47,898 | $0.00 | $0 | N/A | N/A |
EIKN
See Remarks
Award
$997.6K
Thorner Benjamin Bruno67,044 shares @ $14.88
Filed 2026-03-04Trade 2026-03-02
EIKN
10% Owner
Conversion
$0
Column Group Iv Gp, Lp44,249 shares @ $0.00
Filed 2026-02-09Trade 2026-02-06
EIKN
10% Owner
Conversion
$0
Column Group Iv Gp, Lp47,898 shares @ $0.00
Filed 2026-02-09Trade 2026-02-06
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.